• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

SR One

edit

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately $600 million in more than 130 companies. For more information please visit www.srone.com

Milestones

edit

• 
  SR One invested in RaNA Therapeutics. (1/18/12)
  Posted 1/18/12 at 3:57am via masshightech.com
• 
  SR One invested in MISSION Therapeutics. (8/25/11)
  Posted 8/25/11 at 7:36pm via biospace.com
• 
  SR One invested in f-star Biotech. (4/13/11)
  Posted 7/17/11 at 6:02pm via f-star.com
• 
  SR One invested in Nimbus Discovery. (6/28/11)
  Posted 6/28/11 at 4:06am via xconomy.com
• 
  SR One invested in HTG Molecular Diagnostics. (6/13/11)
  Posted 6/13/11 at 6:49pm via finsmes.com
• 
  SR One invested in Constellation Pharmaceuticals. (6/6/11)
  Posted 6/6/11 at 5:47pm via finsmes.com
• 
  SR One invested in Springleaf Therapeutics. (5/12/11)
  Posted 5/12/11 at 12:28am via masshightech.com
• 
  SR One invested in Genocea Biosciences. (1/3/11)
  Posted 1/3/11 at 6:08pm via finsmes.com
• 
  SR One invested in Semprus BioSciences. (12/13/10)
  Posted 12/13/10 at 6:36pm via semprusbio.com
• 
  SR One invested in Syntaxin. (11/11/10)
  Posted 11/11/10 at 6:27pm via fiercebiotech.com
• 
  SR One invested in Dicerna Pharmaceuticals. (10/21/10)
  Posted 10/22/10 at 7:01pm via masshightech.com
• 
  SR One invested in iPierian. (9/9/10)
  Posted 7/8/10 at 7:02pm via dowjones.com
• 
  SR One invested in Constellation Pharmaceuticals. (6/7/10)
  Posted 6/2/10 at 6:47pm via onbiovc.com
• 
  SR One invested in NeuroTherapeutics Pharma. (5/20/10)
  Posted 5/21/10 at 6:31pm via fiercebiotech.com
• 
  SR One invested in Onyvax. (5/8/06)
  Posted 4/22/10 at 4:31am via onyvax.com
• 
  SR One invested in Syntaxin. (10/31/07)
  Posted 3/11/10 at 7:39pm via syntaxin.com

Investments

Videos

Sources

1. RaNA Therapeutics emerges from stealth with $20.7M Series A round (masshightech.com) [edit]
2. MissionTherapeutics Ltd Raises $10 Million, Eyes Rapid Growth (biospace.com) [edit]
3. Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery (xconomy.com) [edit]
4. HTG Molecular Diagnostics Receives $500k from SR One in Series D Financing (finsmes.com) [edit]
5. Constellation Pharmaceuticals Raises $15M in Series B Financing (finsmes.com) [edit]
6. SpringLeaf Therapeutics raises $15M Series B round (masshightech.com) [edit]
7. f-star raises €15M in a New Financing led by SR One (f-star.com) [edit]
8. Genocea Biosciences Closes $35M Series B Financing Round (finsmes.com) [edit]
9. SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION (semprusbio.com) [edit]
10. VCs inject $29M into Syntaxin, $11.5M into Ceregene (fiercebiotech.com) [edit]
11. Dicerna makes $29M second close on Series B funding round (masshightech.com) [edit]
12. IPierian Announces Second Close Of Series B Financing At $28M (fis.dowjones.com) [edit]
13. Constellation Pharmaceuticals, Inc.: Series B $4.8M (onbiovc.com) [edit]
14. Big Pharma firms back $43M round for NeuroTherapeutics (fiercebiotech.com) [edit]
15. CalciMedica Closes Second Tranche of $12M Series C Financing (finsmes.com) [edit]
16. Trinity Biosystems raises $7.5M bridge to treat endocrine disorders (deals.venturebeat.com) [edit]
17. Aileron Therapeutics Closes Series D Financing (zibb.com) [edit]
18. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
19. CalciMedica, Inc.: Series C $4M (onbiovc.com) [edit]
20. Capital Funding Report [edit]
21. Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline (syntaxin.com) [edit]
22. Onyvax Raises £8 Million to Advance Development of Prostate Cancer Vaccine (onyvax.com) [edit]